Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.02%
median of 823 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
MiNK Therapeutics, Inc.
Market Cap
$58.29M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$58.43M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.19M
Net Profit Margin
-86687.50%
TTM Avg
-43373.76%
3Y Avg
-21686.88%
5Y Avg
-14457.92%
Market Cap
$57.09M
Net Profit Margin
-1507600.00%
TTM Avg
-25517.85%
3Y Avg
-13465.42%
5Y Avg
-10648.78%
Market Cap
$59.66M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-69.82%
5Y Avg
-186.89%
Market Cap
$59.83M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$56.40M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$61.08M
Net Profit Margin
0.00%
TTM Avg
-36932.26%
3Y Avg
-34526.76%
5Y Avg
-23017.84%
Market Cap
$61.17M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | $58.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Boundless Bio, Inc. (BOLD)vs › | $58.43M | 0.00% | 0.00% | 0.00% | 0.00% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $59.19M | -86687.50% | -43373.76% | -21686.88% | -14457.92% |
| Talphera, Inc. (TLPH)vs › | $57.09M | -1507600.00% | -25517.85% | -13465.42% | -10648.78% |
| Adicet Bio, Inc. (ACET)vs › | $59.66M | 0.00% | 0.00% | -69.82% | -186.89% |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.83M | 0.00% | 0.00% | 0.00% | 0.00% |
| OKYO Pharma Limited (OKYO)vs › | $56.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fractyl Health, Inc. (GUTS)vs › | $61.08M | 0.00% | -36932.26% | -34526.76% | -23017.84% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Xilio Therapeutics, Inc. (XLO)vs › | $61.35M | -34.06% | -499.05% | -249.52% | -166.35% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
